Gregory R. Blaha, MD, PhD » Punctate Inner Choroidopathy with CNV treated with Bevacizumab

  • Punctate Inner Choroidopathy with CNV Treated with Bevacizumab # 1 of 7

    Feb 28 2013 by Gregory R. Blaha, MD, PhD

    Fundus photograph in a 31-year-old female with vision loss from a choroidal neovascular membrane (CNV) from punctate inner choroidopathy. Note the CNV and hemorrhage superotemporal to the fovea.

    Photographer: Gerard Gauthier, Spindel Eye Associates, Derry, NH

    Imaging device: Zeiss FF 450 Plus

    Condition/keywords: bevacizumab, choroidal neovascularization (CNV), punctate inner choroidopathy (PIC)

  • Punctate Inner Choroidopathy with CNV Treated with Bevacizumab # 2 of 7

    Feb 28 2013 by Gregory R. Blaha, MD, PhD

    Red-free fundus photograph in a 31-year-old female with vision loss from a choroidal neovascular membrane (CNV) from punctate inner choroidopathy. Note the CNV and hemorrhage superotemporal to the fovea.

    Photographer: Gerard Gauthier, Spindel Eye Assoc., Derry, NH

    Imaging device: Zeiss FF 450 Plus

    Condition/keywords: bevacizumab, choroidal neovascularization (CNV), punctate inner choroidopathy (PIC)

  • Punctate Inner Choroidopathy with CNV Treated with Bevacizumab # 3 of 7

    Feb 28 2013 by Gregory R. Blaha, MD, PhD

    Early-phase fluorescein angiogram in a 31-year-old female with vision loss from a choroidal neovascular membrane (CNV) from punctate inner choroidopathy.

    Photographer: Gerard Gauthier, Spindel Eye Assoc., Derry, NH

    Imaging device: Zeiss FF 450 Plus

    Condition/keywords: bevacizumab, choroidal neovascularization (CNV), punctate inner choroidopathy (PIC)

  • Punctate Inner Choroidopathy with CNV Treated with Bevacizumab # 4 of 7

    Feb 28 2013 by Gregory R. Blaha, MD, PhD

    Mid-phase fluorescein angiogram in a 31-year-old female with vision loss from a choroidal neovascular membrane (CNV) from punctate inner choroidopathy.

    Photographer: Gerard Gauthier, Spindel Eye Assoc., Derry, NH

    Imaging device: Zeiss FF 450 Plus

    Condition/keywords: bevacizumab, choroidal neovascularization (CNV), punctate inner choroidopathy (PIC)

  • Punctate Inner Choroidopathy with CNV Treated with Bevacizumab # 5 of 7

    Feb 28 2013 by Gregory R. Blaha, MD, PhD

    Late-phase fluorescein angiogram in a 31-year-old female with vision loss from a choroidal neovascular membrane (CNV) from punctate inner choroidopathy. Note the leakage from the CNV.

    Photographer: Gerard Gauthier, Spindel Eye Assoc., Derry, NH

    Imaging device: Zeiss FF 450 Plus

    Condition/keywords: bevacizumab, choroidal neovascularization (CNV), punctate inner choroidopathy (PIC)

  • Punctate Inner Choroidopathy with CNV Treated with Bevacizumab # 6 of 7

    Feb 28 2013 by Gregory R. Blaha, MD, PhD

    Fundus photo following treatment with bevacizumab in a 31-year-old female with vision loss from a choroidal neovascular membrane (CNV) from punctate inner choroidopathy. The vision improved and was stable following a single injection.

    Photographer: Gerard Gauthier, Spindel Eye Assoc., Derry, NH

    Imaging device: Zeiss FF 450 Plus

    Condition/keywords: bevacizumab, choroidal neovascularization (CNV), punctate inner choroidopathy (PIC)

  • Punctate Inner Choroidopathy with CNV Treated with Bevacizumab # 7 of 7

    Feb 28 2013 by Gregory R. Blaha, MD, PhD

    Improvement in OCT following treatment with bevacizumab in a 31-year-old female with vision loss from a choroidal neovascular membrane (CNV) from punctate inner choroidopathy. The vision improved and was stable following a single injection.

    Photographer: Gerard Gauthier, Spindel Eye Assoc., Derry, NH

    Imaging device: Zeiss Cirrus

    Condition/keywords: bevacizumab, choroidal neovascularization (CNV), punctate inner choroidopathy (PIC)